Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 38 (18), 2397-2406
- https://doi.org/10.1016/s0959-8049(02)00491-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group StudyJournal of Clinical Oncology, 1999
- Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual dataThe Lancet, 1997
- Improving the Quality of Reporting of Randomized Controlled TrialsJAMA, 1996
- The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of viewCritical Reviews in Oncology/Hematology, 1995
- Selection of large and objectively measurable target lesions in EORTC phase II trials: Impact on recruitment and response rateEuropean Journal Of Cancer, 1993
- Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcomaEuropean Journal of Cancer and Clinical Oncology, 1990
- Quality control of validity of data collected in clinical trialsEuropean Journal of Cancer and Clinical Oncology, 1989
- Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma groupEuropean Journal of Cancer and Clinical Oncology, 1987
- Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomasEuropean Journal of Cancer and Clinical Oncology, 1987
- Ifosfamide plus mesna with and without adriamycin in soft tissue sarcomaCancer Chemotherapy and Pharmacology, 1986